324 related articles for article (PubMed ID: 2513570)
1. A humanized antibody that binds to the interleukin 2 receptor.
Queen C; Schneider WP; Selick HE; Payne PW; Landolfi NF; Duncan JF; Avdalovic NM; Levitt M; Junghans RP; Waldmann TA
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10029-33. PubMed ID: 2513570
[TBL] [Abstract][Full Text] [Related]
2. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
[TBL] [Abstract][Full Text] [Related]
3. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.
Mateo C; Moreno E; Amour K; Lombardero J; Harris W; Pérez R
Immunotechnology; 1997 Mar; 3(1):71-81. PubMed ID: 9154469
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
[TBL] [Abstract][Full Text] [Related]
5. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies.
Kolbinger F; Saldanha J; Hardman N; Bendig MM
Protein Eng; 1993 Nov; 6(8):971-80. PubMed ID: 8309946
[TBL] [Abstract][Full Text] [Related]
6. Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter P; Presta L; Gorman CM; Ridgway JB; Henner D; Wong WL; Rowland AM; Kotts C; Carver ME; Shepard HM
Proc Natl Acad Sci U S A; 1992 May; 89(10):4285-9. PubMed ID: 1350088
[TBL] [Abstract][Full Text] [Related]
7. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
[TBL] [Abstract][Full Text] [Related]
8. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
[TBL] [Abstract][Full Text] [Related]
10. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.
Tamura M; Milenic DE; Iwahashi M; Padlan E; Schlom J; Kashmiri SV
J Immunol; 2000 Feb; 164(3):1432-41. PubMed ID: 10640759
[TBL] [Abstract][Full Text] [Related]
11. Chimeric and humanized antibodies with specificity for the CD33 antigen.
Co MS; Avdalovic NM; Caron PC; Avdalovic MV; Scheinberg DA; Queen C
J Immunol; 1992 Feb; 148(4):1149-54. PubMed ID: 1737932
[TBL] [Abstract][Full Text] [Related]
12. A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities.
Rose B; Gillespie A; Wunderlich D; Barbosa JA; Cahill K; Dzuiba J; Shedd D; Zerler B
Mol Immunol; 1992 Jan; 29(1):131-44. PubMed ID: 1731187
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
15. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
[TBL] [Abstract][Full Text] [Related]
16. Humanization of murine monoclonal antibodies through variable domain resurfacing.
Roguska MA; Pedersen JT; Keddy CA; Henry AH; Searle SJ; Lambert JM; Goldmacher VS; Blättler WA; Rees AR; Guild BC
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):969-73. PubMed ID: 8302875
[TBL] [Abstract][Full Text] [Related]
17. The immune response toward beta-adrenergic ligands and their receptors. VIII. Extensive diversity of VH and VL genes encoding anti-alprenolol antibodies.
Nahmias C; Strosberg AD; Emorine LJ
J Immunol; 1988 Feb; 140(4):1304-11. PubMed ID: 3125254
[TBL] [Abstract][Full Text] [Related]
18. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
19. Humanized antibodies for antiviral therapy.
Co MS; Deschamps M; Whitley RJ; Queen C
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2869-73. PubMed ID: 1849279
[TBL] [Abstract][Full Text] [Related]
20. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
